Valuation: Exosens

Market Cap 2.59B 2.86B 2.4B 2.16B 4.08B 270B 4.22B 28.79B 11.42B 144B 10.73B 10.5B 457B P/E 2026 *
30.2x
P/E 2027 * 21.9x
Enterprise Value 2.75B 3.04B 2.54B 2.3B 4.33B 286B 4.48B 30.57B 12.12B 153B 11.39B 11.15B 485B EV / Sales 2026 *
4.87x
EV / Sales 2027 * 4.18x
Free-Float
68.96%
Yield 2026 *
0.7%
Yield 2027 * 1.03%
1 day-2.68%
1 week-1.45%
Current month-10.54%
1 month-12.39%
3 months-23.80%
6 months-11.94%
Current year+5.06%
1 week 50.5
Extreme 50.5
54.95
1 month 50.5
Extreme 50.5
59.65
Current year 48.4
Extreme 48.4
74
1 year 40
Extreme 40
74
3 years 16.84
Extreme 16.842
74
5 years 16.84
Extreme 16.842
74
10 years 16.84
Extreme 16.842
74
Manager TitleAgeSince
Chief Executive Officer 53 01/09/2016
Director of Finance/CFO 53 01/04/2022
Chief Tech/Sci/R&D Officer - 01/07/2022
Director TitleAgeSince
Director/Board Member 53 -
Director/Board Member - -
Chairman 56 -
Date Insider Type Main position Quantity % Market Cap. Importance
14/04/26
HLD Associés SA
SellCompany 1,765,673 3.4664%
14/04/26
HLD Associés SA
SellCompany 484,327 0.9508%
23/03/26 Sell

Chief Executive Officer

45,000 0.0883%
Change 5-day change 1-year change 3-year change Capi.($)
-2.68%-1.45%+11.01% - 2.86B
+0.29%+2.65%+8.85%+182.99% 343B
+0.11%+4.77%+13.11%+146.10% 268B
-0.77%+5.22%+0.07%+56.98% 180B
-1.39%+7.09%+22.12%+465.10% 147B
-1.83%+3.76%+0.72%+95.11% 140B
-1.33%+5.11%+27.97%+34.18% 138B
-0.03%-1.10%-11.83%-17.34% 136B
+0.11%+2.65%+5.58%+46.64% 98.07B
-1.03%+7.29%+8.62%+328.69% 87.81B
Average -0.86%+3.57%+8.62%+148.72% 154B
Weighted average by Cap. -0.48%+3.97%+8.76%+149.40%

Financials

2026 *2027 *
Net sales 565M 624M 523M 472M 889M 58.83B 921M 6.28B 2.49B 31.42B 2.34B 2.29B 99.75B 642M 709M 594M 536M 1.01B 66.82B 1.05B 7.14B 2.83B 35.69B 2.66B 2.6B 113B
Net income 78.47M 86.59M 72.58M 65.48M 123M 8.16B 128M 872M 346M 4.36B 325M 318M 13.84B 115M 126M 106M 95.56M 180M 11.91B 186M 1.27B 504M 6.36B 474M 464M 20.2B
Net Debt 160M 176M 148M 133M 251M 16.61B 260M 1.77B 703M 8.87B 661M 647M 28.16B 91M 100M 84.17M 75.95M 143M 9.47B 148M 1.01B 401M 5.06B 377M 369M 16.06B
Projected Income Statement - Annual - Exosens
Logo Exosens
Exosens specializes in the design, manufacture and marketing of high-tech electro-optical detection and imaging systems for defense and industrial applications. Under the Photonis, Telops, Xenics and El-M brands, the company offers advanced imaging cameras, electron, ion, neutron and gamma detectors, microwave amplifiers and night vision tubes, providing tailor-made solutions for highly demanding environments. At the end of 2025, the group has 12 production sites around the world. Net sales are distributed geographically as follows: France (6.7%), Greece (38.1%), Europe (33.7%), Asia (13.9%), the United States (6.1%), North America (0.9%), Oceania (0.4%), Africa (0.1%) and other (0.1%).
Employees
2,000
Date Price Change Volume
13/11/26 €50.90 -2.68% 127,773
12/11/26 €52.30 -0.95% 117,418
11/11/26 €52.80 -1.86% 51,803
10/11/26 €53.80 +0.37% 80,953
09/11/26 €53.60 +3.78% 60,116
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Exosens
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
50.90EUR
Average target price
69.85EUR
Spread / Average Target
+37.23%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Exosens
  1. Stock Market
  2. Stocks
  3. EXENS Stock